Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Tu, A. Mahmoud, A. Wight, Amelia Mottashed, S. Bélanger, M. Rahim, Elias Abou-Samra, A. Makrigiannis (2014)
Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.Cancer research, 74 14
S. Giebel, F. Locatelli, T. Lamparelli, A. Velardi, S. Davies, G. Frumento, R. Maccario, F. Bonetti, J. Wojnar, M. Martinetti, F. Frassoni, G. Giorgiani, A. Bacigalupo, J. Hołowiecki (2003)
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.Blood, 102 3
Petter Höglund, Claes Öhlén, E. Carbone, L. Franksson, H. Ljunggren, Ann Latour, Beverly Koller, K. Kärre (1991)
Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.Proceedings of the National Academy of Sciences of the United States of America, 88 22
H. Ljunggren, S. Pääbo, M. Cochet, G. Kling, P. Kourilsky, K. Kärre (1989)
Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis.Journal of immunology, 142 8
T. Graef, Achim Moesta, P. Norman, L. Abi-Rached, L. Vago, Anastazia Aguilar, Michael Gleimer, J. Hammond, L. Guethlein, D. Bushnell, P. Robinson, P. Parham (2009)
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-CThe Journal of Experimental Medicine, 206
N. Fernandez, E. Treiner, R. Vance, A. Jamieson, S. Lemieux, D. Raulet (2005)
A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.Blood, 105 11
Jeffery Miller, S. Cooley, P. Parham, S. Farag, M. Verneris, K. McQueen, L. Guethlein, E. Trachtenberg, M. Haagenson, M. Horowitz, J. Klein, D. Weisdorf (2007)
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.Blood, 109 11
Jeffrey Miller, Y. Soignier, A. Panoskaltsis‐Mortari, S. McNearney, Gong Yun, S. Fautsch, D. McKenna, C. Le, T. Defor, L. Burns, P. Orchard, B. Blazar, J. Wagner, A. Slungaard, D. Weisdorf, I. Okazaki, P. Mcglave (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.Blood, 105 8
C. Stewart, F. Laugier-Anfossi, F. Vely, X. Saulquin, Jenifer Riedmuller, Agnès Tisserant, L. Gauthier, F. Romagné, G. Ferracci, Fernando Arosa, A. Moretta, P. Sun, S. Ugolini, É. Vivier (2005)
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.Proceedings of the National Academy of Sciences of the United States of America, 102 37
F. Karlhofer, R. Ribaudo, W. Yokoyama (1992)
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cellsNature, 358
J. Elliott, J. Wahle, W. Yokoyama (2010)
MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environmentThe Journal of Experimental Medicine, 207
L. Veinotte, B. Wilhelm, D. Mager, F. Takei (2003)
Acquisition of MHC-specific receptors on murine natural killer cells.Critical reviews in immunology, 23 4
T. Pradeu, S. Jaeger, É. Vivier (2013)
The speed of change: towards a discontinuity theory of immunity?Nature Reviews Immunology, 13
L. Thomas, M. Peterson, Eric Long (2013)
Cutting Edge: NK Cell Licensing Modulates Adhesion to Target CellsThe Journal of Immunology, 191
N. Wagtmann, R. Biassoni, C. Cantoni, S. Verdiani, M. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, Eric Long (1995)
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.Immunity, 2 5
P. Carrega, B. Morandi, R. Costa, G. Frumento, G. Forte, G. Altavilla, G. Ratto, M. Mingari, L. Moretta, G. Ferlazzo (2008)
Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cellsCancer, 112
N. Valiante, M. Uhrberg, H. Shilling, K. Lienert-Weidenbach, K. Arnett, A. D’Andrea, J. Phillips, L. Lanier, P. Parham (1997)
Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.Immunity, 7 6
R. Kiessling, R. Kiessling, P. Hochman, O. Haller, G. Shearer, H. Wigzell, G. Cudkowicz (1977)
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic graftsEuropean Journal of Immunology, 7
G. Cudkowicz, J. Stimpfling (1964)
Induction of Immunity and of Unresponsiveness to Parental Marrow Grafts in Adult F1 Hybrid MiceNature, 204
R. Glas, K. Sturmhöfel, G. Hämmerling, K. Kärre, H. Ljunggren (1992)
Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cellsThe Journal of Experimental Medicine, 175
H. Ljunggren, C. Ohlen, P. Höglund, T. Yamasaki, G. Klein, K. Kärre (1988)
Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.Journal of immunology, 140 2
Jia-huai Wang, A. Smolyar, K. Tan, Jin‐huan Liu, Mikyung Kim, Zhen-Yu Sun, G. Wagner, E. Reinherz (1999)
Structure of a Heterophilic Adhesion Complex between the Human CD2 and CD58 (LFA-3) CounterreceptorsCell, 97
L. Lanier (2005)
NK cell recognition.Annual review of immunology, 23
Madhavi Challa-Malladi, Y. Lieu, Olivia Califano, A. Holmes, G. Bhagat, V. Murty, D. Dominguez-Sola, L. Pasqualucci, R. Dalla-Favera (2011)
Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.Cancer cell, 20 6
Marloes Gooden, M. Lampen, E. Jordanova, N. Leffers, J. Trimbos, S. Burg, H. Nijman, T. Hall (2011)
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytesProceedings of the National Academy of Sciences, 108
Y. Bryceson, M. March, H. Ljunggren, Eric Long (2006)
Activation, coactivation, and costimulation of resting human natural killer cellsImmunological Reviews, 214
J. Traherne, Maureen Martin, R. Ward, M. Ohashi, F. Pellett, D. Gladman, D. Middleton, M. Carrington, J. Trowsdale (2009)
Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complexHuman Molecular Genetics, 19
N. Liao, M. Bix, M. Zijlstra, R. Jaenisch, D. Raulet (1991)
MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity.Science, 253 5016
V. Braud, D. Allan, C. O'Callaghan, K. Söderström, A. D’Andrea, G. Ogg, S. Lazetic, N. Young, J. Bell, J. Phillips, L. Lanier, A. McMichael (1998)
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and CNature, 391
F. Lehmann, M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, P. Coulie (1995)
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selectionEuropean Journal of Immunology, 25
M. Uhrberg, P. Parham, P. Wernet (2002)
Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genesImmunogenetics, 54
A. Curti, L. Ruggeri, S. Parisi, A. Bontadini, E. Dan, M. Motta, S. Rizzi, S. Trabanelli, D. Ocadlikova, Mariangela Lecciso, V. Giudice, F. Fruet, E. Urbani, C. Papayannidis, G. Martinelli, G. Bandini, F. Bonifazi, R. Lewis, M. Cavo, A. Velardi, R. Lemoli (2016)
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia PatientsClinical Cancer Research, 22
T. Ebihara, A. Jonsson, W. Yokoyama (2013)
Natural killer cell licensing in mice with inducible expression of MHC class IProceedings of the National Academy of Sciences, 110
Nicolas Anfossi, P. André, S. Guia, Christine Falk, Sophie Roetynck, C. Stewart, V. Breso, Coralie Frassati, D. Reviron, D. Middleton, F. Romagné, S. Ugolini, É. Vivier (2006)
Human NK cell education by inhibitory receptors for MHC class I.Immunity, 25 2
Sungjin Kim, Jennifer Poursine‐Laurent, S. Truscott, L. Lybarger, Yun-Jeong Song, Liping Yang, A. French, J. Sunwoo, S. Lemieux, T. Hansen, W. Yokoyama (2005)
Licensing of natural killer cells by host major histocompatibility complex class I moleculesNature, 436
J. Goodridge, Aura Burian, N. Lee, D. Geraghty (2013)
HLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like ReceptorsThe Journal of Immunology, 191
H. Shilling, L. Guethlein, Nathalie Cheng, C. Gardiner, Roberto Rodríguez, D. Tyan, P. Parham (2002)
Allelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype1The Journal of Immunology, 168
S. Kanner, N. Damle, James Blake, A. Aruffo, J. Ledbetter (1992)
CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.Journal of immunology, 148 7
A. Horowitz, Zakia Djaoud, Neda Nemat-Gorgani, J. Blokhuis, H. Hilton, V. Béziat, Karl-Johan Malmberg, P. Norman, L. Guethlein, P. Parham (2016)
Class I HLA haplotypes form two schools that educate NK cells in different waysScience Immunology, 1
M. Vitale, C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, A. Moretta (1998)
NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell LysisThe Journal of Experimental Medicine, 187
María Valenzuela-Membrives, Francisco Perea-García, A. Sánchez-Palencia, F. Ruiz-Cabello, M. Gómez‐Morales, M. Miranda-León, Inmaculada Galindo-Angel, M. Fárez-Vidal (2016)
Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancerOncotarget, 7
F. Marincola, Peter Shamamian, T. Simonis, A. Abati, Julia Hackett, Teresita O'Dea, P. Fetsch, J. Yannelli, N. Restifo, J. Mulé, Steven Rosenberg (1994)
Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines.Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 16 1
R. Vance, Jennifer Kraft, J. Altman, P. Jensen, D. Raulet (1998)
Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1bThe Journal of Experimental Medicine, 188
F. Garrido, F. Perea, M. Bernal, A. Sánchez-Palencia, N. Aptsiauri, F. Ruiz-Cabello (2017)
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue ArchitectureVaccines, 5
K. Kärre, H. Ljunggren, G. Piontek, R. Kiessling (1986)
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 319
A. Ribas, O. Hamid, A. Daud, F. Hodi, J. Wolchok, R. Kefford, R. Kefford, A. Joshua, A. Patnaik, W. Hwu, J. Weber, T. Gangadhar, P. Hersey, R. Dronca, R. Joseph, H. Zarour, B. Chmielowski, D. Lawrence, A. Algazi, N. Rizvi, Brianna Hoffner, C. Mateus, K. Gergich, Jill Lindia, M. Giannotti, Xiaoyun Li, S. Ebbinghaus, S. Kang, C. Robert (2016)
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.JAMA, 315 15
Karl-Johan Malmberg, H. Ljunggren (2006)
Escape from immune- and nonimmune-mediated tumor surveillance.Seminars in cancer biology, 16 1
M. Yawata, N. Yawata, M. Draghi, F. Partheniou, A. Little, P. Parham (2008)
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.Blood, 112 6
L. Ruggeri, M. Capanni, M. Casucci, I. Volpi, A. Tosti, K. Perruccio, E. Urbani, R. Negrin, M. Martelli, A. Velardi (1999)
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.Blood, 94 1
(2014)
A (2014) PD-1 blockade
H. Symons, M. Leffell, N. Rossiter, M. Zahurak, Richard Jones, E. Fuchs (2010)
Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 16 4
H. Wende, M. Colonna, A. Ziegler, A. Volz (1999)
Organization of the leukocyte receptor cluster (LRC) on human Chromosome 19q13.4Mammalian Genome, 10
Shasha Chen, Meixiang Yang, Juan Du, Dan Li, Zehua Li, Chenxu Cai, Yuanwu Ma, Lianfeng Zhang, Z. Tian, Zhongjun Dong (2016)
The Self-Specific Activation Receptor SLAM Family Is Critical for NK Cell Education.Immunity, 45 2
O. Hamid, C. Robert, A. Daud, F. Hodi, W. Hwu, R. Kefford, J. Wolchok, P. Hersey, R. Joseph, J. Weber, R. Dronca, T. Gangadhar, A. Patnaik, H. Zarour, A. Joshua, K. Gergich, J. Elassaiss-Schaap, A. Algazi, C. Mateus, P. Boasberg, P. Tumeh, B. Chmielowski, S. Ebbinghaus, Xiaoyun Li, S. Kang, A. Ribas (2013)
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.The New England journal of medicine, 369 2
J. Zaretsky, A. García-Díaz, D. Shin, Helena Escuin-Ordinas, Willy Hugo, S. Hu-Lieskovan, D. Torrejon, Gabriel Abril-Rodriguez, Salemiz Sandoval, Lucas Barthly, Justin Saco, B. Moreno, R. Mezzadra, B. Chmielowski, K. Ruchalski, I. Shintaku, P. Sanchez, C. Puig-Saus, Grace Cherry, E. Seja, X. Kong, Jia Pang, B. Berent-Maoz, B. Comin-Anduix, T. Graeber, P. Tumeh, T. Schumacher, R. Lo, A. Ribas (2016)
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.The New England journal of medicine, 375 9
R. Schreiber, L. Old, M. Smyth (2011)
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionScience, 331
A. Pessino, S. Sivori, C. Bottino, A. Malaspina, L. Morelli, L. Moretta, R. Biassoni, A. Moretta (1998)
Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural CytotoxicityThe Journal of Experimental Medicine, 188
Stephen Anderson (2006)
Transcriptional regulation of NK cell receptors.Current topics in microbiology and immunology, 298
H. Ljunggren, N. Stam, Claes Öhlén, J. Neefjes, P. Höglund, M. Heemels, J. Bastin, T. Schumacher, A. Townsend, K. Kärre, H. Ploegh (1990)
Empty MHC class I molecules come out in the coldNature, 346
Lisa Liu, Aline Pfefferle, Vincent Sheng, A. Björklund, V. Béziat, J. Goodridge, Karl-Johan Malmberg (2015)
Harnessing adaptive natural killer cells in cancer immunotherapyMolecular Oncology, 9
P. Prieto, J. Yang, R. Sherry, M. Hughes, U. Kammula, D. White, Catherine Levy, S. Rosenberg, G. Phan (2012)
CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic MelanomaClinical Cancer Research, 18
B. Seliger, T. Cabrera, F. Garrido, S. Ferrone (2002)
HLA class I antigen abnormalities and immune escape by malignant cells.Seminars in cancer biology, 12 1
R. Bolhuis, R. Roozemond, R. Griend (1986)
Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.Journal of immunology, 136 11
V. Béziat, Lisa Liu, Jenny-Ann Malmberg, Martin Ivarsson, Ebba Sohlberg, A. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, M. Schaffer, D. Price, J. Trowsdale, J. Michaëlsson, H. Ljunggren, Karl-Johan Malmberg (2013)
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.Blood, 121 14
D. Pende, S. Marcenaro, M. Falco, S. Martini, M. Bernardo, D. Montagna, E. Romeo, C. Cognet, M. Martinetti, R. Maccario, M. Mingari, É. Vivier, L. Moretta, F. Locatelli, A. Moretta (2009)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.Blood, 113 13
H. Ljunggren, K. Sturmhöfel, E. Wolpert, G. Hämmerling, K. Kärre (1990)
Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.Journal of immunology, 145 1
H. Ljunggren, K. Kärre (1985)
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanismThe Journal of Experimental Medicine, 162
S. Andersson, C. Fauriat, Jenny-Ann Malmberg, H. Ljunggren, Karl-Johan Malmberg (2009)
KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression.Blood, 114 1
A. Moretta, M. Vitale, S. Sivori, C. Bottino, L. Morelli, R. Augugliaro, M. Barbaresi, D. Pende, E. Ciccone, M. López-Botet, Lorenzo Morettar (1994)
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B allelesThe Journal of Experimental Medicine, 180
M. Uhrberg, N. Valiante, B. Shum, H. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. Lanier, P. Parham (1997)
Human diversity in killer cell inhibitory receptor genes.Immunity, 7 6
M. Corat, Heinrich Schlums, Chuanfeng Wu, J. Theorell, Diego Espinoza, S. Sellers, D. Townsley, N. Young, Y. Bryceson, C. Dunbar, T. Winkler (2017)
Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs.Blood, 129 14
J. Bukur, S. Jasinski, B. Seliger (2012)
The role of classical and non-classical HLA class I antigens in human tumors.Seminars in cancer biology, 22 4
P. Parham (2005)
MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 5
R. Kiessling, E. Klein, H. Wigzell (1975)
„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotypeEuropean Journal of Immunology, 5
S. Rosenberg, J. Yang, P. Robbins, J. Wunderlich, P. Hwu, R. Sherry, D. Schwartzentruber, S. Topalian, N. Restifo, A. Filie, R. Chang, M. Dudley (2003)
Cell Transfer Therapy for Cancer: Lessons from Sequential Treatments of a Patient With Metastatic MelanomaJournal of Immunotherapy, 26
D. Knorr, V. Bachanova, M. Verneris, Jeffrey Miller (2014)
Clinical utility of natural killer cells in cancer therapy and transplantation.Seminars in immunology, 26 2
N. Restifo, F. Marincola, Y. Kawakami, J. Taubenberger, J. Yannelli, S. Rosenberg (1996)
Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.Journal of the National Cancer Institute, 88 2
H. Ljunggren, K. Kärre (1990)
In search of the 'missing self': MHC molecules and NK cell recognition.Immunology today, 11 7
N. Joncker, N. Shifrin, Frédéric Delebecque, D. Raulet (2010)
Mature natural killer cells reset their responsiveness when exposed to an altered MHC environmentThe Journal of Experimental Medicine, 207
A. Sucker, F. Zhao, B. Real, Christina Heeke, Nicola Bielefeld, Stefan Maβen, S. Horn, Iris Moll, Raffaela Maltaner, P. Horn, B. Schilling, F. Sabbatino, V. Lennerz, M. Kloor, S. Ferrone, D. Schadendorf, C. Falk, K. Griewank, A. Paschen (2014)
Genetic Evolution of T-cell Resistance in the Course of Melanoma ProgressionClinical Cancer Research, 20
Lisa Liu, V. Béziat, V. Oei, Aline Pfefferle, M. Schaffer, S. Lehmann, E. Hellström-Lindberg, S. Söderhäll, M. Heyman, D. Grandér, Karl-Johan Malmberg (2017)
Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia CellsCancer Immunology Research, 5
Charlotte Viant, A. Fenis, G. Chicanne, B. Payrastre, S. Ugolini, É. Vivier (2014)
SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cellsNature Communications, 5
L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M. Martelli, A. Velardi (2002)
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 295
P. Tumeh, C. Harview, J. Yearley, I. Shintaku, E. Taylor, L. Robert, B. Chmielowski, M. Spasić, G. Henry, V. Ciobanu, Alisha West, M. Carmona, C. Kivork, E. Seja, Grace Cherry, Antonio Gutierrez, T. Grogan, C. Mateus, G. Tomasic, J. Glaspy, R. Emerson, H. Robins, R. Pierce, D. Elashoff, C. Robert, A. Ribas (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistanceNature, 515
Heinrich Schlums, M. Jung, Hongya Han, J. Theorell, V. Bigley, S. Chiang, D. Allan, J. Davidson-Moncada, R. Dickinson, T. Holmes, A. Hsu, D. Townsley, T. Winkler, Weixin Wang, P. Aukrust, I. Nordøy, K. Calvo, S. Holland, M. Collin, C. Dunbar, Y. Bryceson (2017)
Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.Blood, 129 14
D. Schadendorf, F. Hodi, C. Robert, J. Weber, K. Margolin, O. Hamid, D. Patt, Tai-Tsang Chen, D. Berman, J. Wolchok (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 17
S. Guia, Baptiste Jaeger, S. Piatek, S. Mailfert, T. Trombik, A. Fenis, Nicolas Chevrier, T. Walzer, Y. Kerdiles, D. Marguet, É. Vivier, S. Ugolini (2011)
Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell ToleranceScience Signaling, 4
M. Uhrberg (2005)
Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation.Molecular immunology, 42 4
K. Kärre (2008)
Natural killer cell recognition of missing selfNature Immunology, 9
J. Yewdell, A. Hill (2002)
Viral interference with antigen presentationNature Immunology, 3
F. Garrido, N. Aptsiauri, E. Doorduijn, A. Lora, T. Hall (2016)
The urgent need to recover MHC class I in cancers for effective immunotherapyCurrent Opinion in Immunology, 39
L. Ramal, I. Maleno, T. Cabrera, A. Collado, A. Ferrón, M. López-Nevot, Federico Garrido (2000)
Molecular strategies to define HLA haplotype loss in microdissected tumor cells.Human immunology, 61 10
P. Parham (2008)
The genetic and evolutionary balances in human NK cell receptor diversity.Seminars in immunology, 20 6
M. Carlsten, Bettina Baumann, M. Simonsson, M. Jädersten, A. Forsblom, C. Hammarstedt, Y. Bryceson, H. Ljunggren, E. Hellström-Lindberg, Karl-Johan Malmberg (2010)
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndromeLeukemia, 24
H. Khong, N. Restifo (2002)
Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 3
H. Ljunggren, Toshiki Yamasaki, Peter Collins, George Klein, K. Kárre (1988)
Selective acceptance of MHC class I-deficient tumor grafts in the brainThe Journal of Experimental Medicine, 167
C. Fauriat, S. Andersson, A. Björklund, M. Carlsten, M. Schaffer, N. Björkström, Bettina Baumann, J. Michaëlsson, H. Ljunggren, Karl-Johan Malmberg (2008)
Estimation of the Size of the Alloreactive NK Cell Repertoire: Studies in Individuals Homozygous for the Group A KIR Haplotype1The Journal of Immunology, 181
C. Gardiner, L. Guethlein, H. Shilling, M. Pando, W. Carr, R. Rajalingam, C. Vilches, P. Parham (2001)
Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism1The Journal of Immunology, 166
S. Bauer, V. Groh, Jun-ying Wu, A. Steinle, J. Phillips, L. Lanier, T. Spies (1999)
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.Science, 285 5428
R. Biassoni, A. Pessino, A. Malaspina, C. Cantoni, C. Bottino, S. Sivori, L. Moretta, A. Moretta (1997)
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA‐Cw4 moleculesEuropean Journal of Immunology, 27
The ability of NK cells to specifically recognize cells lacking expression of self-MHC class I molecules was discovered over 30 years ago. It provided the foundation for the “missing self” hypothesis. Research in the two past decades has contributed to a detailed understanding of the molecular mechanisms that determine the specificity and strength of NK cell-mediated “missing self” responses to tumor cells. However, in light of the recent remarkable breakthroughs in clinical cancer immunotherapy, the cytolytic potential of NK cells still remains largely untapped in clinical settings. There is abundant evidence demonstrating partial or complete loss of HLA class I expression in a wide spectrum of human tumor types. Such loss may result from immune selection of escape variants by tumor-specific CD8 T cells and has more recently also been linked to acquired resistance to checkpoint inhibition therapy. In the present review, we discuss the early predictions of the “missing self” hypothesis, its molecular basis and outline the potential for NK cell-based adoptive immunotherapy to convert checkpoint inhibitor therapy-resistant patients into clinical responders.
Immunogenetics – Springer Journals
Published: Jul 11, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.